The product discovery work undertaken by the company hits the 4 key reasons promising diagnostics technologies fail in the clinic. The discovery process:

• Addresses all the issues faced in the clinic from the start. Transfer from the research lab into the clinic is the key failure point for diagnostics under development. By dealing with the complexity of the clinic from the start, Biosignatures ensures its products are robust.
• Uses blind testing throughout to ensure that the results reported are reliable and that any unreliable tests are weeded out early.
• Applies industrial level rigour and repeatability to the processes used. (ISO 9001 certification is in process, ISO 13485 will follow shortly after).
• Samples large numbers of patients from the outset to fully model the diversity in presenting populations.